Search Results - Jon Thor Asmussen
You must be logged in first
- Showing 1 - 7 results of 7
-
1
Cost-effectiveness of 2-[18F]FDG-PET/CT versus CE-CT for response monitoring in patients with metastatic breast cancer: a register-based comparative study by Mohammad Naghavi-Behzad, Oke Gerke, Annette Raskov Kodahl, Marianne Vogsen, Jon Thor Asmussen, Wolfgang Weber, Malene Grubbe Hildebrandt, Kristian Kidholm
Published 2023-09-01
Article -
2
P919: TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WITH ZOLEDRONIC ACID FOR FOUR YEARS INSTEAD OF TWO YEARS DECREASES RISK OF PROGRESSIVE BONE DISEASE WITHOUT INCREASING RISK OF OST... by Michael Gundesen, Fredrik Schjesvold, Annette Vangsted, Carsten Helleberg, Einar Haukås, Trine Silkjær, Elena Todorescu, Bo Amdi Jensen, Tobias S. Slørdahl, Jon Thor Asmussen, Hareth Nahi, Anders Waage, Niels Abildgaard, Thomas Lund
Published 2023-08-01
Article -
3
Benefits and harms of implementing [18F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study by Marianne Vogsen, Jeanette Dupont Jensen, Oke Gerke, Anne Marie Bak Jylling, Jon Thor Asmussen, Ivar Yannick Christensen, Poul-Erik Braad, Peter Thye-Rønn, Katrine Lydolph Søe, Marianne Ewertz, Malene Grubbe Hildebrandt
Published 2021-09-01
Article -
4
2-[18F]FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer by Marianne Vogsen, Mohammad Naghavi-Behzad, Frederik Graae Harbo, Nick Møldrup Jakobsen, Oke Gerke, Jon Thor Asmussen, Henriette Juel Nissen, Sara Elisabeth Dahlsgaard-Wallenius, Poul-Erik Braad, Jeanette Dupont Jensen, Marianne Ewertz, Malene Grubbe Hildebrandt
Published 2023-04-01
Article -
5
Potential value of pre-planned imaging of bone disease in multiple myeloma by Michael T. Gundesen, Jon Thor Asmussen, Fredrik Schjesvold, Annette Juul Vangsted, Carsten Helleberg, Einar Haukås, Trine Silkjær, Elena Manuela Teodorescu, Bo Amdi Jensen, Tobias S. Slørdahl, Hareth Nahi, Anders Waage, Niels Abildgaard, Thomas Lund, Nordic Myeloma Study Group
Published 2023-07-01
Article -
6
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease by Thomas Lund, Michael Tveden Gundesen, Annette Juul Vangsted, Carsten Helleberg, Einar Haukås, Trine Silkjær, Jon Thor Asmussen, Elena Manuela Teodorescu, Bo Amdi Jensen, Tobias Schmidt Slørdahl, Hareth Nahi, Anders Waage, Niels Abildgaard, Fredrik Schjesvold, Nordic Myeloma Study Group
Published 2024-04-01
Article -
7
A randomised trial of [18F]PSMA‐1007‐PET/CT versus NaF‐PET/CT for staging primary prostate cancer: A trial protocol by Karen Middelbo Buch‐Olsen, Mads Hvid Poulsen, Steinbjørn Hansen, Mie Holm Vilstrup, Jorun Holm, Søren Hess, Paw Christian Holdgaard, Karsten Egbert Arnold Zieger, Søren Sørensen Madsen, Oke Gerke, Kasper Tholstrup Pedersen, Johan Hygum Dam, Niels Langkjær, Louise Dorner Østergaard, Jon Thor Asmussen, Poul Erik Braad, Birgitte Nørgaard, Matthias Eiber, Malene Grubbe Hildebrandt
Published 2023-09-01
Article